Barker RA - Search Results

1

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention.

Lawson RA, Yarnall AJ, Duncan GW, Breen DP, Khoo TK, Williams-Gray CH, Barker RA, Collerton D, Taylor JP, Burn DJ; ICICLE-PD study group. Lawson RA, et al. Among authors: barker ra. Parkinsonism Relat Disord. 2016 Jun;27:47-53. doi: 10.1016/j.parkreldis.2016.04.009. Epub 2016 Apr 11. Parkinsonism Relat Disord. 2016. PMID: 27094482 Free PMC article.

2

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Foltynie T, Brayne CE, Robbins TW, Barker RA. Foltynie T, et al. Among authors: barker ra. Brain. 2004 Mar;127(Pt 3):550-60. doi: 10.1093/brain/awh067. Epub 2003 Dec 22. Brain. 2004. PMID: 14691062

3

No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease.

Williams-Gray CH, Goris A, Foltynie T, Brown J, Maranian M, Walton A, Compston DA, Sawcer SJ, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. Mov Disord. 2006 May;21(5):731-2. doi: 10.1002/mds.20863. Mov Disord. 2006. PMID: 16552758 No abstract available.

4

Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. CNS Drugs. 2006;20(6):477-505. doi: 10.2165/00023210-200620060-00004. CNS Drugs. 2006. PMID: 16734499 Review.

5

The role of learned irrelevance in attentional set-shifting impairments in Parkinson's disease.

Slabosz A, Lewis SJ, Smigasiewicz K, Szymura B, Barker RA, Owen AM. Slabosz A, et al. Among authors: barker ra. Neuropsychology. 2006 Sep;20(5):578-88. doi: 10.1037/0894-4105.20.5.578. Neuropsychology. 2006. PMID: 16938020 Clinical Trial.

6

Visual hallucinations predict increased benefits from rivastigmine in Parkinson's disease dementia.

Williams-Gray CH, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. Nat Clin Pract Neurol. 2007 May;3(5):250-1. doi: 10.1038/ncpneuro0471. Epub 2007 Mar 20. Nat Clin Pract Neurol. 2007. PMID: 17375057 No abstract available.

7

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

Williams-Gray CH, Hampshire A, Robbins TW, Owen AM, Barker RA. Williams-Gray CH, et al. Among authors: barker ra. J Neurosci. 2007 May 2;27(18):4832-8. doi: 10.1523/JNEUROSCI.0774-07.2007. J Neurosci. 2007. PMID: 17475791 Free PMC article.

8

Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease.

Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJ, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ. Goris A, et al. Among authors: barker ra. Ann Neurol. 2007 Aug;62(2):145-53. doi: 10.1002/ana.21192. Ann Neurol. 2007. PMID: 17683088

9

Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype.

Williams-Gray CH, Hampshire A, Barker RA, Owen AM. Williams-Gray CH, et al. Among authors: barker ra. Brain. 2008 Feb;131(Pt 2):397-408. doi: 10.1093/brain/awm313. Epub 2008 Jan 4. Brain. 2008. PMID: 18178571

10

A pathophysiological model of freezing of gait in Parkinson's disease.

Lewis SJ, Barker RA. Lewis SJ, et al. Among authors: barker ra. Parkinsonism Relat Disord. 2009 Jun;15(5):333-8. doi: 10.1016/j.parkreldis.2008.08.006. Epub 2008 Oct 17. Parkinsonism Relat Disord. 2009. PMID: 18930430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters